The power of phase II end-points for different possible mechanisms of action of an experimental treatment

por Wason, J.M.S., Dentamaro, A., Eisen, T.G.
Publicado 2015

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

por Morris, S L, Low, S H, A'Hern, R P, Eisen, T G, Gore, M E, Nutting, C M, Harrington, K J
Publicado 2004

Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009–2010)

por Liniker, E, Harrison, M, Weaver, J M J, Agrawal, N, Chhabra, A, Kingshott, V, Bailey, S, Eisen, T G G, Corrie, P G
Publicado 2013

A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma

por Larkin, J M G, Hughes, S A, Beirne, D A, Patel, P M, Gibbens, I M, Bate, S C, Thomas, K, Eisen, T G, Gore, M E
Publicado 2007